Last reviewed · How we verify
NCT06748170: AIDRARER
Al to Improve the Diagnosis of Rare Rheumatic Diseases
NA trial testing ChatGPT in Rheumatic Diseases in 68 participants. Completed in 30 March 2025.
30 March 2025
Quick facts
| Lead sponsor | Philipps University Marburg |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | diagnostic |
| Enrollment | 68 |
| Start date | 7 January 2025 |
| Primary completion | 30 March 2025 |
| Estimated completion | 30 March 2025 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- ChatGPT
Conditions studied
- Rheumatic Diseases — all drugs for Rheumatic Diseases →
Sponsor
Philipps University Marburg
Who can join
18 and older, any sex, with Rheumatic Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial aims to assess the impact of providing medical students with access to ChatGPT, a state-of-the-art large language model, in comparison to conventional diagnostic decision support tools, on their diagnostic accuracy for rare rheumatic diseases.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Large language models enhance diagnostic reasoning of medical students in rheumatology: a randomized controlled trial.
Roemer A, Schlicker N, Kernder A, Albe B, et al · · 2026 · PMID 41877128 · DOI 10.1186/s12909-026-09079-w
Verify or expand the search:
- PubMed search for NCT06748170
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ChatGPT
Trials testing the same drug.
- NCT07100366 — Comparing Sarcopenia , Physical, Psychological and Social Frailty in Hospitalized Older Women Congestive Heart Failure i · NA · not yet recruiting
- NCT07091435 — ChatGPT -Based Intervention for Social Frailty in Older Women With CHF : Gender Differences · NA · not yet recruiting
- NCT06863792 — ChatGPT-Assisted Hypertension Knowledge in Nursing Students · NA · not yet recruiting
- NCT06384950 — Evaluating the Role of ChatGPT in Educating Patients With Early-stage Hepatocellular Carcinoma · NA · recruiting
Other recruiting trials for Rheumatic Diseases
Currently open trials in the same condition.
- NCT07490041 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refr · EARLY_PHASE1 · recruiting
- NCT07350395 — Exploring and Measuring the Impact of Steroids in Children and Young People · recruiting
- NCT07278609 — The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions · recruiting
- NCT07148414 — A Study of SPY072 in Rheumatic Disease · Phase 2 · recruiting
- NCT06400628 — Effectiveness of Chronic Self-management Education on Behavioral and Clinical Outcomes · NA · recruiting
Other Philipps University Marburg trials
Trials by the same sponsor.
- NCT07498803 — Sota-ES - Sotatercept in Patients With Congenital Heart Disease and Eisenmenger´s Syndrome · Phase 2 · not yet recruiting
- NCT07388004 — Group Therapy for Major Depression: Comparing Expectation-Focused and Reward-Focused Psychotherapy Approaches · NA · recruiting
- NCT07166692 — Evaluation of a Retrieval Augmented Large Language Model as a Diagnostic Copilot in Rheumatology · NA · completed
- NCT06865534 — Large Language Models to Aid Gynecological Oncology Treatment · NA · recruiting
- NCT06968897 — Neurological Development In Toddlers After Maternal SARS-CoV-2 Infection During Pregnancy · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06748170 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Philipps University Marburg
- Last refreshed: 29 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06748170.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing